Description
Erlocip 100 mg is a prescription medicine for patients with non-small cell lung cancer whose cancer has spread to other body areas. It contains the active substance Erlotinib which treats cancer by preventing the activity of a protein called epidermal growth factor receptor (EGFR). This protein is responsible for the growth and spread of cancer cells. The medicine is indicated for adults with non-small cell lung cancer at an advanced stage. Doctors may prescribe this as initial therapy or in cases where the condition remains unchanged after initial chemotherapy, provided your cancer cells have specific EGFR mutations. Your doctor may also prescribe this drug in combination with another medication called gemcitabine if you have cancer growth in pancreas at a metastatic stage.


















Reviews
There are no reviews yet.